Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sangaletti

Showing results (251-260 of 281) with videos related to

Pageof 29
Sort By:
Ebiomedicine|October 23, 2020
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfacesSabina Sangaletti, Fabio Iannelli, Federica Zanardi, et al.
Iscience|October 21, 2020
A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell LymphomasClaudio Tripodo, Federica Zanardi, Fabio Iannelli, et al.
Oncogene|February 2, 2019
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancerLorenzo Castagnoli, Valeria Cancila, Sandra L Cordoba-Romero, et al.
Blood|September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansionClaudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Frontiers in Immunology|January 10, 2018
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic CellsMariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2025
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on TregsGiovanna Talarico, Mara Lecchi, Anna Zanichelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T CellsGiulia Corradi, Barbara Bassani, Giorgia Simonetti, et al.
Cancer Research|February 20, 2019
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor CellsCristina Travelli, Francesca Maria Consonni, Sabina Sangaletti, et al.
Blood Advances|June 13, 2022
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathyCelia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, et al.
Cytokine & Growth Factor Reviews|November 6, 2018
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meetingF De Santis, M Del Vecchio, L Castagnoli, et al.
Pageof 29

Showing results (251-260 of 281) with videos related to

Sort By:
Pageof 29
Ebiomedicine|October 23, 2020
Intra-tumour heterogeneity of diffuse large B-cell lymphoma involves the induction of diversified stroma-tumour interfacesSabina Sangaletti, Fabio Iannelli, Federica Zanardi, et al.
Iscience|October 21, 2020
A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell LymphomasClaudio Tripodo, Federica Zanardi, Fabio Iannelli, et al.
Oncogene|February 2, 2019
WNT signaling modulates PD-L1 expression in the stem cell compartment of triple-negative breast cancerLorenzo Castagnoli, Valeria Cancila, Sandra L Cordoba-Romero, et al.
Blood|September 8, 2012
Stromal SPARC contributes to the detrimental fibrotic changes associated with myeloproliferation whereas its deficiency favors myeloid cell expansionClaudio Tripodo, Sabina Sangaletti, Carla Guarnotta, et al.
Frontiers in Immunology|January 10, 2018
ATP Release from Chemotherapy-Treated Dying Leukemia Cells Elicits an Immune Suppressive Effect by Increasing Regulatory T Cells and Tolerogenic Dendritic CellsMariangela Lecciso, Darina Ocadlikova, Sabina Sangaletti, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 2, 2025
ECM-Induced IL-23 Drives Immune Suppression in Breast Cancer via Regulating PD-1 on TregsGiovanna Talarico, Mara Lecchi, Anna Zanichelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 29, 2022
Release of IFNγ by Acute Myeloid Leukemia Cells Remodels Bone Marrow Immune Microenvironment by Inducing Regulatory T CellsGiulia Corradi, Barbara Bassani, Giorgia Simonetti, et al.
Cancer Research|February 20, 2019
Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor CellsCristina Travelli, Francesca Maria Consonni, Sabina Sangaletti, et al.
Blood Advances|June 13, 2022
CIC-39Na reverses the thrombocytopenia that characterizes tubular aggregate myopathyCelia Cordero-Sanchez, Emanuela Pessolano, Beatrice Riva, et al.
Cytokine & Growth Factor Reviews|November 6, 2018
Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meetingF De Santis, M Del Vecchio, L Castagnoli, et al.
Pageof 29